R. Carter Pate is Director at Option Care Health, Inc. (OPCH). They have made 16 open-market trades across 5 companies since 2016, most recently 2026-05-20.
CIK 0001641406
8 open-market purchases totalling $348K since 2016, against 8 sales. Across 8 scored buys the stock is down 1.7% at ninety days, and 7.8 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 38% | 50% |
| Avg Move | +1.6% | -0.4% | -1.7% |
| Alpha | +0.4% | -4.0% | -7.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPCH | SELL | 2026-02-27 | 2026-03-03 | $32.05 | $971K | -5.2% | -11.1% | -33.8% |
| OPCH | BUY | 2025-08-20 | 2025-08-21 | $27.19 | $20K | +0.3% | -0.6% | -3.7% |
| OPCH | SELL | 2024-09-03 | 2024-09-05 | $32.37 | $47K | -4.2% | -13.0% | -27.4% |
| OPCH | BUY | 2023-08-17 | 2023-08-21 | $34.32 | $101K | -1.3% | -3.5% | -15.9% |
| PRPL | BUY | 2023-05-15 | 2023-05-15 | $2.95 | $50K | +8.8% | -3.9% | -24.2% |
| OPCH | SELL | 2022-10-03 | 2022-10-05 | $31.97 | $123K | +0.3% | -6.4% | -12.4% |
| OPCH | SELL | 2022-09-01 | 2022-09-02 | $30.65 | $118K | +4.9% | +6.3% | +0.5% |
| OPCH | SELL | 2022-08-01 | 2022-08-03 | $33.37 | $128K | +1.6% | -11.7% | -12.3% |
| OPCH | SELL | 2022-07-08 | 2022-07-12 | $30.00 | $58K | +11.3% | +17.8% | +13.9% |
| OPCH | SELL | 2021-12-21 | 2022-06-03 | $28.52 | $256K | -8.5% | -5.8% | +1.3% |
| TLGT | BUY | 2021-05-27 | 2021-05-27 | $0.55 | $17K | +6.2% | +2.8% | -29.7% |
| OPCH | BUY | 2021-05-10 | 2021-05-12 | $16.74 | $14K | +10.2% | +22.7% | +25.5% |
| PRSC | SELL | 2019-11-11 | 2019-11-13 | $69.67 | $70K | -6.1% | -11.6% | +4.5% |
| PRSC | BUY | 2019-08-13 | 2019-08-15 | $57.97 | $58K | -3.8% | +5.6% | +11.1% |
| BIOS | BUY | 2016-11-10 | 2016-11-14 | $1.30 | $26K | -2.1% | -22.9% | +15.0% |
| BIOS | BUY | 2016-06-17 | 2016-06-20 | $2.50 | $63K | -5.6% | -3.3% | +8.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $7.7M |
Shares reported on the most recent Form 4, priced at the 2026-05-22 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.